5049 Ammonium transporter-related
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 2 | 6.3 | 0.32× | q = 0.04 | |
| Organometallic compounds | 1 | 0.0 | 55× | not tested | |
| Lipids and lipid-like molecules | 9 | 1.4 | 6.31× | not tested | |
| Organic nitrogen compounds | 1 | 0.4 | 2.45× | not tested | |
| Organoheterocyclic compounds | 4 | 2.0 | 2.03× | not tested | |
| Homogeneous non-metal compounds | 3 | 2.8 | 1.09× | not tested | |
| Organic acids and derivatives | 2 | 2.0 | 1.01× | not tested | |
| Nucleosides, nucleotides, and analogues | 3 | 3.5 | 0.85× | not tested | |
| Organic oxygen compounds | 1 | 2.6 | 0.39× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00140 | RBF | Riboflavin | 10 |
| DB03247 | FMN | Flavin mononucleotide | 10 |
| DB02379 | BGC | Beta-D-Glucose | 6 |
| DB04540 | CLR | Cholesterol | 6 |
| DB04327 | PEE | Phosphatidylethanolamine | 3 |
| DB08690 | UQ2 | Ubiquinone Q2 | 2 |
| DB01828 | NME | Methylamine | 1 |
| DB02451 | BNG | B-nonylglucoside | 1 |
| DB09157 | CO2 | Carbon dioxide | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| FMN | FLAVIN MONONUCLEOTIDE | 34 |
| RBF | RIBOFLAVIN | 34 |
| 3PE | 1,2-Distearoyl-sn-glycerophosphoethanolamine | 7 |
| AJP | Digitonin | 7 |
| PTY | PHOSPHATIDYLETHANOLAMINE | 7 |
| A1LU9 | N-(4-acetamidophenyl)-5-ethanoyl-furan-2-carboxamide | 6 |
| BGC | beta-D-glucopyranose | 6 |
| CLR | CHOLESTEROL | 6 |
| NAmetal | SODIUM ION | 6 |
| P6L | (2S)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(6E)-HEXADEC-6-ENOYLOXY]PROPYL (8E)-OCTADEC-8-ENOATE | 6 |
| PEE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 6 |
| SPL | OCTANOIC ACID (2-HYDROXY-1-HYDROXYMETHYL-HEPTADEC-3-ENYL)-AMIDE | 6 |
| URE | UREA | 6 |
| CL | CHLORIDE ION | 4 |
| Y01 | CHOLESTEROL HEMISUCCINATE | 4 |
| 5D3 | 10-(4-ethylphenyl)sulfonyl-~{N}-(thiophen-2-ylmethyl)-5-thia-1,8,11,12-tetrazatricyclo[7.3.0.0^{2,6}]dodeca-2(6),3,7,9,11-pentaen-7-amine | 3 |
| 8HC | 8-hydroxyquinoline-2-carboxylic acid | 3 |
| A1EJ7 | 5-ethanoyl-~{N}-[3-(phenylsulfonylamino)phenyl]furan-2-carboxamide | 3 |
| A1LVA | N-[3-[1,1-bis(oxidanylidene)-1,2-thiazolidin-2-yl]-4-chloranyl-phenyl]-2-methoxy-5-methyl-benzenesulfonamide | 3 |
| A1LYJ | (5E)-2-azanylidene-5-[(2,3-dimethoxyphenyl)methylidene]-1,3-thiazolidin-4-one | 3 |